1. South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, and
2. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington;
3. Department of Molecular Microbiology, Washington University in St. Louis, St. Louis, Missouri;
4. Division of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa;
5. Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, Australia;
6. The Aurum Institute, Johannesburg, Guateng, South Africa;
7. Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research and SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa;
8. Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa;
9. Medical Research Council-CAPRISA HIV-Tuberculosis Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa; and
10. School of Public Health, University of Witwatersrand, Johannesburg, South Africa